Blogs


kyrie 1

date:2015-9-6
kyrie 1

While Allergan and Teva Pharmaceuticals announce this deal, both Perrigo (NYSE:PRGO) and Mylan should both take it very seriously. While both companies were early reluctant to be purchased, a reconsideration kyrie 1 of this position would likely serve them both well. Teva Pharmaceuticals will be abandoning its pursuit of Mylan, which now leaves the firm without a potential acquirer, which should lead to the evaporation of the deal premium that is baked into the stock.